Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

The Longevity Fund

Investor type Micro VC
Founders Laura Deming

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 22
Average round size
info
The average size of a deal this fund participated in
$29M
Portfolio companies 17
Rounds per year 2.00
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.23
Exits 4
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Biopharma
Summary

The main office of represented VC is situated in the San Francisco. The company was established in North America in United States.

The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ALX Oncology, Decibel Therapeutics, Fauna Bio. Among the most popular fund investment industries, there are Content Discovery, Health Care.

The fund is generally included in 2-6 deals every year. The top activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2019. Opposing the other organizations, this The Longevity Fund works on 7 percentage points less the average amount of lead investments.

The current fund was established by Laura Deming. Besides them, we counted 1 critical employee of this fund in our database.

The usual cause for the fund is to invest in rounds with 9-10 partakers. Despite the The Longevity Fund, startups are often financed by Venrock, General Catalyst, Elad Gil. The meaningful sponsors for the fund in investment in the same round are General Catalyst, Elad Gil, Caffeinated Capital. In the next rounds fund is usually obtained by General Catalyst, Elad Gil, Caffeinated Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of The Longevity Fund:
Typical Co-investors
The Longevity Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after The Longevity Fund:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
365.fintech District of Zvolen, Region of Banská Bystrica, Slovakia
Apposite Capital England, London, United Kingdom
Harvard Angel Group Boston, Massachusetts, United States
Invivo Capital Partners Barcelona, Catalonia, Spain
MRW Enterprises LLC -
Panoramic Ventures Atlanta, Georgia, United States
ProQuest Investments New Jersey, Princeton, United States
SHINMEI Japan, Tokyo
Stableton Financial Switzerland, Zug, Zug

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Loyal

Biotechnology
Pet
Veterinary
$27M23 Sep 2021 San Francisco, California, United States

EDocate

Ediscovery
EdTech
Education
Health Care
Training
$3M29 Apr 2021 Tel Aviv-Yafo, Tel Aviv District, Israel

Rubedo Life Sciences

Biotechnology
Health Care
$12M03 Dec 2020 Sunnyvale, California, United States

Elevian

Biopharma
Biotechnology
$15M24 Nov 2020 Boston, Massachusetts, United States

Wellth

Health Care
Information Technology
mHealth
Personal Health
$1M19 Jun 2020 Los Angeles, California, United States

Celevity

Biotechnology
Health Care
Life Science
Pet
$4M03 Jan 2020 San Francisco, California, United States

Loyal

Biotechnology
Pet
Veterinary
$11M01 Jan 2020 San Francisco, California, United States

Epirium

Biopharma
Biotechnology
Health Care
Life Science
$85M19 Dec 2019 San Diego, California, United States

Cardero Therapeutics

Biotechnology
Health Care
Therapeutics
$85M18 Dec 2019 California, United States
News
Loyal raises $27M, aims to give dog owners more time with their pets

– San Francisco startup Loyal raised $27m in Series A funding.
– The round was led by Khosla Ventures and included First Round Capital, Box Group, Collaborative Fund, The Longevity Fund and Lachy Groom.
– The company is building an animal pharmaceutical company that is developing therapeutics aimed at extending both lifespan and healthspan for dogs.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent The Longevity Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: